# Greater Metropolitan Community Blood Service Inc. – FDA Inspection, Mar 11, 2026

Source: https://www.keypedia.com/records/fda_inspections/greater-metropolitan-community-blood-service-inc/c95bba3c-965a-46c0-877d-5a4e3c388f54
Source feed: FDA_Inspections

> FDA inspection 1310512 of Greater Metropolitan Community Blood Service Inc., March 11, 2026. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1310512
- Company Name: Greater Metropolitan Community Blood Service Inc.
- Inspection Date: 2026-03-11
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1194098 - 2022-12-14
- [FDA Inspection 1064397 - 2018-08-31](https://www.keypedia.com/records/fda_inspections/greater-metropolitan-community-blood-service-inc/545ddc16-8e84-47f1-b0fc-22a2cf03a0e1)
- FDA Inspection 947400 - 2015-11-05
- FDA Inspection 858069 - 2013-12-16
- FDA Inspection 764160 - 2012-01-24

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/amy-a-johnson/9933f793-503f-45c5-8837-d46134c20e09)

Company: https://www.keypedia.com/companies/greater-metropolitan-community-blood-service-inc/7bb28ba8-da2a-4b8a-ba8b-01c1e11f1b93

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d